Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Cell Death Differ ; 18(5): 769-82, 2011 May.
Article in English | MEDLINE | ID: mdl-21113145

ABSTRACT

Loss of parkin function is responsible for the majority of autosomal recessive parkinsonism. Here, we show that parkin is not only a stress-protective, but also a stress-inducible protein. Both mitochondrial and endoplasmic reticulum (ER) stress induce an increase in parkin-specific mRNA and protein levels. The stress-induced upregulation of parkin is mediated by ATF4, a transcription factor of the unfolded protein response (UPR) that binds to a specific CREB/ATF site within the parkin promoter. Interestingly, c-Jun can bind to the same site, but acts as a transcriptional repressor of parkin gene expression. We also present evidence that mitochondrial damage can induce ER stress, leading to the activation of the UPR, and thereby to an upregulation of parkin expression. Vice versa, ER stress results in mitochondrial damage, which can be prevented by parkin. Notably, the activity of parkin to protect cells from stress-induced cell death is independent of the proteasome, indicating that proteasomal degradation of parkin substrates cannot explain the cytoprotective activity of parkin. Our study supports the notion that parkin has a role in the interorganellar crosstalk between the ER and mitochondria to promote cell survival under stress, suggesting that both ER and mitochondrial stress can contribute to the pathogenesis of Parkinson's disease.


Subject(s)
Activating Transcription Factor 4/metabolism , Endoplasmic Reticulum/physiology , Mitochondria/physiology , Stress, Physiological , Ubiquitin-Protein Ligases/genetics , Base Sequence , Carbonyl Cyanide m-Chlorophenyl Hydrazone/pharmacology , Cell Death , Cell Line , Endoplasmic Reticulum/drug effects , Enzyme Inhibitors/adverse effects , Genes, Reporter , Humans , Ionophores/pharmacology , Luciferases, Renilla/biosynthesis , Membrane Potential, Mitochondrial , Mitochondria/drug effects , Promoter Regions, Genetic , Proteasome Endopeptidase Complex/physiology , Proto-Oncogene Proteins c-jun/metabolism , RNA Interference , Response Elements/genetics , Signal Transduction , Thapsigargin/adverse effects , Transcription, Genetic , Ubiquitin-Protein Ligases/metabolism , Unfolded Protein Response , Up-Regulation , eIF-2 Kinase/metabolism
2.
Hum Mol Genet ; 19(19): 3734-46, 2010 Oct 01.
Article in English | MEDLINE | ID: mdl-20639397

ABSTRACT

Growing evidence highlights a role for mitochondrial dysfunction and oxidative stress as underlying contributors to Parkinson's disease (PD) pathogenesis. DJ-1 (PARK7) is a recently identified recessive familial PD gene. Its loss leads to increased susceptibility of neurons to oxidative stress and death. However, its mechanism of action is not fully understood. Presently, we report that DJ-1 deficiency in cell lines, cultured neurons, mouse brain and lymphoblast cells derived from DJ-1 patients display aberrant mitochondrial morphology. We also show that these DJ-1-dependent mitochondrial defects contribute to oxidative stress-induced sensitivity to cell death since reversal of this fragmented mitochondrial phenotype abrogates neuronal cell death. Reactive oxygen species (ROS) appear to play a critical role in the observed defects, as ROS scavengers rescue the phenotype and mitochondria isolated from DJ-1 deficient animals produce more ROS compared with control. Importantly, the aberrant mitochondrial phenotype can be rescued by the expression of Pink1 and Parkin, two PD-linked genes involved in regulating mitochondrial dynamics and quality control. Finally, we show that DJ-1 deficiency leads to altered autophagy in murine and human cells. Our findings define a mechanism by which the DJ-1-dependent mitochondrial defects contribute to the increased sensitivity to oxidative stress-induced cell death that has been previously reported.


Subject(s)
Intracellular Signaling Peptides and Proteins/deficiency , Intracellular Signaling Peptides and Proteins/genetics , Mitochondria/genetics , Mitochondria/pathology , Oncogene Proteins/deficiency , Oncogene Proteins/genetics , Parkinson Disease/genetics , Acetylcysteine/pharmacology , Animals , Autophagy/drug effects , Brain/metabolism , Brain/pathology , Cell Death/drug effects , Cell Line , Humans , Mice , Mitochondria/drug effects , Mitochondria/ultrastructure , Mutant Proteins/metabolism , Neostriatum/drug effects , Neostriatum/metabolism , Neostriatum/pathology , Neostriatum/ultrastructure , Neurons/drug effects , Neurons/enzymology , Neurons/pathology , Neurons/ultrastructure , Parkinson Disease/pathology , Peroxiredoxins , Phenotype , Protein Deglycase DJ-1 , Protein Kinases/metabolism , Reactive Oxygen Species/metabolism , Ubiquitin-Protein Ligases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL